Active Biotech AB (0GQU) AI Stock Analysis

0 Followers

Active Biotech AB

(LSE:0GQU)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low LeverageVery limited debt reduces fixed financial obligations and leaves the company less exposed to interest costs or refinancing pressure. This provides some balance-sheet flexibility while Active Biotech advances its development programs, although operating losses still require careful funding management.

Negative Factors

No Reported RevenueThe absence of reported revenue means the company has not yet demonstrated commercial monetization of its development activities. This leaves financial performance dependent on future partnering, milestone, licensing, or product outcomes rather than an established recurring revenue base.

Active Biotech AB (0GQU) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: SEK 94.90M
Dividend Yield: ―
Average Volume (3M): 922
Price to Earnings (P/E): -5.0
Beta (1Y): 1.75
Revenue Growth: ―
EPS Growth: 51.09%
Country: UK
Employees: 5
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Active Biotech AB Business Overview & Revenue Model

Company Description

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which...

Active Biotech AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GB:0GQU against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:CANTA	61Neutral	SEK 403.18M	2.06	63.09%	―	―	―
SE:HNSA	53Neutral	SEK 4.55B	-5.89	―	―	68.88%	10.63%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:ONCO	44Neutral	SEK 759.19M	-2.78	―	―	65.37%	43.28%
SE:SYNACT	44Neutral	SEK 846.58M	-8.54	-60.58%	―	―	14.35%
SE:BINV	43Neutral	SEK 198.73M	-0.39	-128.54%	―	-83.67%	-50.29%

* Healthcare Sector Average

Performance Comparison

GB:0GQU and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0GQU	Active Biotech AB	3.19	-3.23	-50.29%
SE:HNSA	Hansa Biopharma	46.28	20.04	76.37%
SE:BINV	BioInvent International AB	2.92	-26.98	-90.23%
SE:ONCO	Oncopeptides AB	1.75	-3.15	-64.26%
SE:SYNACT	SynAct Pharma AB	15.98	-5.12	-24.27%
SE:CANTA	Cantargia AB	1.40	-2.05	-59.39%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Active Biotech AB AI Stock Analysis